Avalo Therapeutics (AVTX) Inventory Average (2018 - 2023)

Avalo Therapeutics (AVTX) has 6 years of Inventory Average data on file, last reported at $18500.0 in Q2 2023.

• Quarterly Inventory Average fell 22.92% year-over-year to $18500.0 in Q2 2023, while the trailing twelve-month figure through Jun 2023 was $18500.0 (down 22.92% YoY) and the FY2022 annual result came in at $29000.0, up 41.46% from the prior year.
• Inventory Average declined to $18500.0 in Q2 2023, from $19500.0 in the prior quarter.
• In the past five years, Inventory Average ranged from a high of $682452.5 in Q1 2019 to a low of $6030.0 in Q4 2020.
• A 5-year average of $80425.1 and a median of $20250.0 in 2022 frame the typical range for Inventory Average.
• Annual changes were most pronounced in 2020 — Inventory Average plunged 97.24% — and 2021, when it surged 347.76%.
• Tracing AVTX's Inventory Average over 5 years: stood at $211800.5 in 2019, then plunged by 97.15% to $6030.0 in 2020, then surged by 347.76% to $27000.0 in 2021, then decreased by 22.22% to $21000.0 in 2022, then fell by 11.9% to $18500.0 in 2023.
• The last three Inventory Average figures came in at $18500.0 (Q2 2023), $19500.0 (Q1 2023), and $21000.0 (Q4 2022), per Business Quant data.